Prostate Cancer

Evolution of Active Surveillance of Prostate Cancer: Impact of MRI, MRI-guided Biopsy and Focal Therapy. April 24, 2025

Prognostic Value of the Circulating Tumor DNA Fraction in Metastatic Castration-resistant Prostate Cancer: Results from the ProBio Platform Trial. April 24, 2025

Perioperative complications of focal therapy for prostate cancer: results from the GeRmAn Nationwide inpatient Data (GRAND) study. April 24, 2025

Inferred clonal hematopoiesis from tumor DNA sequencing among men with prostate cancer: correlation with somatic tumor alterations and outcomes. April 24, 2025

Genetics of prostate cancer. April 24, 2025

A Retrospective Review of the Impact of Racial Disparities and Outcomes on Urinary Anastomotic Leak in Radical Prostatectomy in a National Surgical Registry. April 23, 2025

Attributes and Health Care Resource Utilization of Patients on Enzalutamide or Abiraterone for Metastatic Castration-Resistant Cancer in England. April 23, 2025

Novel Skp1 inhibitor has potent preclinical efficacy against castration-resistant prostate cancer. April 23, 2025

The impact of androgen receptor pathway inhibitors as starting treatment in metastatic castration-sensitive prostate cancer on patient outcomes (OASIS Japan). April 23, 2025

Characterisation of Multiparametric Magnetic Resonance Imaging of the Prostate in Younger Men with Normal Prostate-specific Antigen Within the PROBASE Study. April 23, 2025

Targeting All Multiple Magnetic Resonance Imaging Prostate Lesions Does Not Enhance Cancer Detection: Insights from the YAU Prostate Cancer Group. April 22, 2025

Real-world analyses of major adverse cardiovascular events and mortality risk after androgen deprivation therapy initiation in black vs. white prostate cancer patients. April 22, 2025

Histology-resolved proteomics reveals distinct tumor and stromal profiles in low- and high-grade prostate cancer. April 22, 2025

How Does Routine Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Modify the Current Management of Prostate Cancer? A Multidisciplinary View. April 22, 2025

Current and future directions in theranostics for neuroendocrine prostate cancer. April 22, 2025

Genetic Drivers of Quality of Life in Prostate Cancer: An Evaluation of Genetic Polymorphisms and Patient-reported Outcomes in the E3805 CHAARTED trial. April 21, 2025

Safety and quality of life of PSMA-PET- and MRI-based focal dose escalated radiotherapy for intermediate- and high-risk prostate cancer: Primary endpoint analysis of the bi-centric phase II HypoFocal trial (ARO2020-01). April 21, 2025

Patient satisfaction and decision regret in patients undergoing radical prostatectomy: a multicenter analysis. April 21, 2025

Revisiting Skull Metastases of Prostate Cancer at Prostate-Specific Membrane Antigen (PSMA) Positron Emission Tomography/Computed Tomography Era: PSMA Uptake Characteristics and Oncological Outcomes. April 21, 2025

BRCA mutations and prostate cancer: should urologist improve daily clinical practice? April 21, 2025

Page 1 of 1473